Baclofen

DB00181ApprovedInvestigationalSmall moleculegamma-Aminobutyric Acid-ergic Agonist

Baclofen is a GABA-ergic agonist used to manage severe spasticity of cerebral or spinal origin in adult and pediatric patients. Baclofen is a gamma-aminobutyric acid (GABA) agonist used as a skeletal muscle relaxant.

Chemical structure of Baclofen
Mechanism
Curator reviewed · 3 references
Primary indication
Oral baclofen is indicated for the treatment of spasticity resulting from multiple sclerosis and is particularly useful for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.Curator reviewed · 9 structured indications
Formula / weight
C10H12ClNO2 · 213.661 g/mol (avg)
First approval
Canada, 1996 · United States, 1977
Also known as
DL-Baclofen
Brand names
  • Fleqsuvy
  • Gablofen
  • Kemstro
  • Lioresal
  • Lyvispah
  • Ozobax

Resolves to

Structure
InChIKeyKPYSYYIEGFHWSV-UHFFFAOYSA-NSMILESNCC(CC(O)=O)C1=CC=C(Cl)C=C1

What you can answer from here — as of September 20, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,795Drug interactionsStructured to mechanism, not free text
Sign in
101Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
5ContraindicationsEach with its own population and attribute set
Sign in
681Marketed productsAcross 11 countries and 175 labellers
Sign in
1ATC codeIncluding every combination product, plus 20 drug categories
Sign in
36+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Baclofen, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account